Table 1.
Main clinical parameters and serum Maresin-1 levels in all participants.
| Variables | non-NAFLD | NAFLD | P-value |
|---|---|---|---|
| Male/Female | 57/59 | 77/47 | 0.029 |
| Age (year) | 41.50 (33.00-51.00) | 45.50 (35.00-53.00) | 0.286 |
| BMI (kg/m2) | 22.54 (21.20-24.20) | 27.26 (25.48-29.49) | 0.000 |
| WC (cm) | 79.68 ± 8.52 | 90.39 ± 7.92 | 0.000 |
| HC (cm) | 95.00 (91.00-98.00) | 100.00 (96.00-104.75) | 0.000 |
| WHR | 0.84 ± 0.06 | 0.89 ± 0.05 | 0.000 |
| SBP (mmHg) | 118.00 (110.00-124.00) | 130.50 (119.00-138.00) | 0.000 |
| DBP (mmHg) | 71.45 ± 9.21 | 77.29 ± 10.68 | 0.000 |
| FBG (mmol/L) | 4.95 (4.68-5.23) | 5.32 (4.90-5.75) | 0.000 |
| WBC (*10^9/L) | 6.11 ± 1.22 | 6.75 ± 1.35 | 0.000 |
| NEU (*10^9/L) | 3.65 ± 0.92 | 3.85 ± 0.95 | 0.099 |
| ALT (U/L) | 18.20 (13.30-27.20) | 27.90 (21.25-42.05) | 0.000 |
| AST (U/L) | 20.20 (17.30-26.05) | 23.40 (19.43-27.50) | 0.002 |
| AST/ALT | 1.15 (0.92-1.34) | 0.83 (0.66-0.99) | 0.000 |
| TP (g/L) | 73.00 ± 3.01 | 72.63 ± 2.93 | 0.328 |
| ALB (g/L) | 46.25 (45.00-47.63) | 46.05 (45.03-47.80) | 0.970 |
| GLO (g/L) | 26.62 ± 2.52 | 26.25 ± 2.59 | 0.260 |
| A/G | 1.76 (1.62-1.90) | 1.77 (1.65-1.91) | 0.501 |
| GGT (U/L) | 16.05 (13.10-26.85) | 31.55 (20.58-48.60) | 0.000 |
| ALP (U/L) | 67.40 (53.95-79.78) | 74.05 (62.55-88.05) | 0.003 |
| Urea (mol/L) | 4.70 (3.90-5.63) | 5.13 (4.59-5.93) | 0.004 |
| UA (μmol/L) | 320.00 (261.48-380.78) | 370.15 (316.65-440.00) | 0.000 |
| Crea (μmol/L) | 63.35 (53.80-71.40) | 70.50 (55.75-77.23) | 0.006 |
| TC (mmol/L) | 4.73 ± 0.77 | 4.95 ± 0.72 | 0.022 |
| TG (mmol/L) | 1.16 (0.84-1.67) | 2.00 (1.42-2.67) | 0.000 |
| HDL-C (mmol/L) | 1.35 (1.17-1.66) | 1.08 (0.96-1.22) | 0.000 |
| LDL-C (mmol/L) | 3.10 ± 0.83 | 3.42 ± 0.70 | 0.002 |
| HCY (μmol/L) | 9.55 (8.00-11.50) | 10.65 (8.80-12.10) | 0.009 |
| Maresin-1 (pg/mL) | 73.11 (65.12-84.50) | 63.63 (59.87-73.93) | 0.000 |